Hi, what are you looking for?
Jewish Business News
Search results for "teva"
Business
Teva Pharmaceutical Industries Ltd has announced today two offerings totaling approximately $6.75 billion of ordinary and preferred shares to fund its takeover of Allergan Plc’s...
Business
Teva to Receive Worldwide Development and Commercial Rights to Novel CGRP Antagonists; Heptares to Receive $10 Million Upfront with up to $400 Million in...
Life science
Pfizer will hold a 10% stake in the Israeli company, as part of its acquisition of Allergan.
Business
Teva will become a leading pharmaceutical company in Mexico, the second largest market in Latin America and one of the top five emerging markets...
Business
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) announced today that the the Japanese Ministry of Health, Labour and Welfare has approved once-daily...
Business
Gecko has developed a cloud-based solution to simplify chronic respiratory disease management through remote monitoring.
Business
IBM has selected Israeli Teva Pharmaceutical Industries Ltd. as its first foundational life sciences partner for the Watson Health Cloud. Financial terms of the partnership...
Business
The acquisition gives Teva exclusive rights to Immuneering's cutting-edge analytics to advance treatments for diseases of the CNS.
Business
Teva CFO Eyal Desheh: We appreciate the strong support we received which stems from the compelling economics of this transaction
Business
Teva bought its 4.6% stake in Mylan at prices of $69-74 per share. the share price is down sharply in premarket trading.